Document is current
Any future updates will be listed below
-
Authors
Rosenblum, Daniel
Joshi, Nitin
Tao, Wei https://orcid.org/0000-0002-4277-3728
Karp, Jeffrey M.
Peer, Dan https://orcid.org/0000-0001-8238-0673
- License Information
-
More Information
Article History
Received: 21 August 2017
Accepted: 5 March 2018
First Online: 12 April 2018
Competing interests
: D.P. declares financial interest in Quiet Therapeutics, ART Biosciences, and SEPL pharma. J.M.K. holds equity in Alivio Therapeutics, a company that has an option to license IP generated by J.M.K. and that may benefit financially if the IP is licensed and further validated. The interests of J.M.K were reviewed and are subject to a management plan overseen by his institution in accordance with its conflict of interest policies. The remaining authors declare no competing interests.
